Results 191 to 200 of about 12,044 (250)

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases. [PDF]

Front Immunol
Ma T, Zhu Y, Zhu R.
europepmc   +1 more source

Local Use of Dexamethasone in the Treatment of Ocular Myasthenia Gravis

, 2020
Minghua Shi, Yingjia Ye, Junping Zhou, Aijiao Qin, Jing Cheng, Hongxing Ren   +5 more
openalex   +1 more source

Effectiveness of Immunosuppressive Therapy in Preventing the Progression of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Nall S, Majeed J, Ahmed Mohsen Alrashidi A, Alhneif M, Hannan Asghar A, Mubarik A, Ahmed Mohsen Alrashidi I, Allahwala D.   +7 more
europepmc   +1 more source

Evaluating the Effectiveness of Large Language Models in Providing Patient Education for Chinese Patients With Ocular Myasthenia Gravis: Mixed Methods Study. [PDF]

J Med Internet Res
Wei B, Yao L, Hu X, Hu Y, Rao J, Ji Y, Dong Z, Duan Y, Wu X.   +8 more
europepmc   +1 more source

Intravenous Efgartigimod Alfa as Initial Monotherapy for Disabling Ocular Myasthenia in an Elderly Patient with Multiple Comorbidities. [PDF]

Cureus
Inzirillo K, Carranza O, Swerdloff MA.
europepmc   +1 more source

Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report

Arwa Qaqish, Arwa Al Anber, Ghada Abdelhafez   +2 more
openalex   +1 more source

Eosinophilic Orbital Myositis Superseding Ocular Myasthenia. [PDF]

Mediterr J Rheumatol
Hasbani GE, Tarhini A, Wehbe R, Ghieh D, Farhat L, Uthman I.   +5 more
europepmc   +1 more source

Uraemic brainstem encephalopathy mimicking ocular myasthenia: a case report. [PDF]

BMC Neurol
Ruwanpathirana P, Chang T.
europepmc   +1 more source

Juvenile ocular myasthenia gravis: a report of two cases. [PDF]

Digit J Ophthalmol
Gabbard R, Yi R, Pratt J, Chang K, Keck K.   +4 more
europepmc   +1 more source

Ocular Myasthenia Gravis As Unilateral Ptosis and External Ophthalmoplegia: A Case Report. [PDF]

Cureus
Tanveer S, Tahir A, Ahmad O, Bibi K, Khan S.   +4 more
europepmc   +1 more source